#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Urethral valves Skin angiosarcoma Cardiomyopathy Hepatoblastoma Giant cell tumour of tendon sheath Glycogen storage disease type I Bronchopulmonary aspergillosis Cortical dysplasia Neuropathic arthropathy Gastroenteropancreatic neuroendocrine tumour disease Chronic myeloid leukaemia Skin cancer Hereditary optic atrophy Chronic inflammatory demyelinating polyradiculoneuropathy Growth hormone deficiency More trials…

    Learn about Rare Diseases

    Biotinidase deficiency Congenital generalised lipodystrophy Idiopathic pulmonary fibrosis – Trials in Disease Immunodeficiency congenital – Diagnostics Alagille syndrome – Trials in Disease Paraneoplastic neurological syndrome Hypereosinophilic syndrome Primary immunodeficiency syndrome – Treatment KBG syndrome – Treatment Cerebral arteriovenous malformation haemorrhagic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BENZYDAMINE HYDROCHLORIDE Fedratinib Diclofenac Epolamine Tapentadol Hydrochloride Ivosidenib VIPOGLANSTAT Mepolizumab D-Camphor Peppermint Oil Esk-001 Denosumab Yttrium-90 Etidronate Disodium Ep262 Surzebiclimab Azd5492 Sxr1096 Zanidatamab Dazukibart AUROCELL-TX More therapies…

    Learn about Your Condition

    Immunosuppression Choroid melanoma Hereditary optic atrophy Urinary tract infection Hypothyroidism Myelodysplastic syndrome Actinic keratosis Hodgkin's disease Insomnia Pertussis Abdominal infection Myxofibrosarcoma Juvenile psoriatic arthritis Leukaemia Eye inflammation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatic cirrhosis

  • Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Bio89-100
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study on the Safety and Effectiveness of Human Plasma Proteins and Glutathione for Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Glutathione (Reduced), Sodium Salt
    • Human Plasma Proteins With Not Less Than 96% Albumin
    Italy

  • Study on Stopping Esomeprazole in Patients with Liver Cirrhosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Placebo
    Germany

  • Study on Dapagliflozin for Patients with Decompensated Liver Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    • Hepatic cirrhosis
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study on Human Serum Albumin and Sodium Chloride for Patients with Liver Cirrhosis and Ascites

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Belgium Denmark Germany Hungary The Netherlands Slovakia +1

  • Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Drugs:
    • Efruxifermin
    Belgium Denmark France Germany Greece Italy +2
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!